The Centre for Human Psychopharmacology conducts world-leading research embracing:
- Cognition and mood enhancement focusing on the effects of natural substances
- Pharmacological and nutraceutical treatments for neurocognitive ageing
- Immediate and long-term effects of illicit and prescription drugs on neurocognition and applied behaviours such as driving
The CHP is a leading international centre researching the cognitive and mood effects of bioactive nutrients, pharmaceuticals, recreational drugs and dietary interventions. The Centre works closely with industry to allow rapid translation of research findings into evidence-based end-user benefits for cognitive health.
We have expertise in the following areas:
News and Events
CHP PhD candidate Roy Hardman talks to ScienceLine about diet and Alzheimer’s disease prevention.
CHP director, Professor Andrew Scholey, is an invited speaker at the Royal Society in London. His talk 'Bioactive nutrients for neurocognitive enhancement in health and disease' is part of the nutrition and mental health and wellbeing conference.
CHP's Professor Andrew Scholey talked to ABC national radio on June 7th about our clinical trial on curcumin. Listen to the interview here